Literature DB >> 16670460

Microcarcinoma of the thyroid.

Zubair W Baloch1, Virginia A LiVolsi.   

Abstract

Thyroid microcarcinoma, defined as a thyroid tumor measuring 1 cm or less, is an extremely indolent tumor. Papillary microcarcinoma, the most common subtype, is often identified incidentally in a thyroid removed for benign clinical nodules or diffuse processes (eg, thyroiditis). In this clinical situation, over 99% are cured by simple lobectomy. In the less common scenario, the microcarcinoma is the primary lesion to a lymph node metastasis presenting clinically as a neck mass; in this situation, the tumor should be treated as a clinical cancer. Other rare microcarcinomas can occur and, of these, the most recently described is micromedullary carcinoma. In the familial setting, these lesions are identified in prophylactic thyroidectomies and are not unexpected findings. However, when found as sporadic tumors, their implications are still unknown. The histologic features, pathologic mimics, and molecular facets of these microscopic neoplasms are discussed in this review.

Entities:  

Mesh:

Year:  2006        PMID: 16670460     DOI: 10.1097/01.pap.0000213006.10362.17

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  17 in total

1.  BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study.

Authors:  Giovanni Tallini; Dario de Biase; Cosimo Durante; Giorgia Acquaviva; Michele Bisceglia; Rocco Bruno; Maria Letizia Bacchi Reggiani; Gian Piero Casadei; Giuseppe Costante; Nadia Cremonini; Livia Lamartina; Domenico Meringolo; Francesco Nardi; Annalisa Pession; Kerry J Rhoden; Giuseppe Ronga; Massimo Torlontano; Antonella Verrienti; Michela Visani; Sebastiano Filetti
Journal:  Mod Pathol       Date:  2015-08-14       Impact factor: 7.842

Review 2.  Surgical management of medullary thyroid carcinoma.

Authors:  Agathoklis Konstantinidis; Michael Stang; Sanziana A Roman; Julie Ann Sosa
Journal:  Updates Surg       Date:  2017-04-13

3.  Pathology of thyroglossal duct: an institutional experience.

Authors:  Shuanzeng Wei; Virginia A LiVolsi; Zubair W Baloch
Journal:  Endocr Pathol       Date:  2015-03       Impact factor: 3.943

4.  Papillary microcarcinoma of the thyroid among atomic bomb survivors: tumor characteristics and radiation risk.

Authors:  Yuzo Hayashi; Frederic Lagarde; Nobuo Tsuda; Sachiyo Funamoto; Dale L Preston; Kojiro Koyama; Kiyohiko Mabuchi; Elaine Ron; Kazunori Kodama; Shoji Tokuoka
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

5.  [Surgery of thyroid carcinoma].

Authors:  H Dralle; K Lorenz; A Machens
Journal:  Chirurg       Date:  2009-11       Impact factor: 0.955

6.  Differential expression of dysadherin in papillary thyroid carcinoma and microcarcinoma: correlation with E-cadherin.

Authors:  Anna Batistatou; Konstantinos Charalabopoulos; Yukihiro Nakanishi; Constantine Vagianos; Setsuo Hirohashi; Niki J Agnantis; Chrissoula D Scopa
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

7.  Intraoperative Frozen Biopsy of Central Lymph Node in the Management of Papillary Thyroid Microcarcinoma.

Authors:  Dong Hoon Lee; Tae Mi Yoon; Hee Kyung Kim; Joon Kyoo Lee; Ho Cheol Kang; Sang Chul Lim
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-09-15

Review 8.  Familial non-medullary thyroid carcinoma: an update.

Authors:  Vânia Nosé
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

9.  Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer.

Authors:  Jen-Der Lin
Journal:  Med Oncol       Date:  2009-06-09       Impact factor: 3.064

10.  Prevalence of thyroid cancer at a medical screening center: pathological features of screen-detected thyroid carcinomas.

Authors:  Yoon Jung Choi; Yong Lai Park; Jang Hyun Koh
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.